{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T09:22:18Z","timestamp":1781083338813,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bulcan.2022.03.014","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T08:00:55Z","timestamp":1654156855000},"page":"S56-S66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S","title":["Complications cardiaques de la greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\u00a0: recommandations de la SFGM-TC"],"prefix":"10.1016","volume":"110","author":[{"given":"Imran","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Souchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fati","family":"Hamzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Desbrosses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Ravinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Turlure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Villate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Borel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanane","family":"Benbarkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Guillaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11S","key":"10.1016\/j.bulcan.2022.03.014_bib0230","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"Ateliers d\u2019harmonisation des pratiques de la SFGM-TC","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"issue":"15","key":"10.1016\/j.bulcan.2022.03.014_bib0235","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2012-09-455063","article-title":"How I assess comorbidities before hematopoietic cell transplantation","volume":"121","author":"Sorror","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2022.03.014_bib0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijcard.2019.05.032","article-title":"Moderate or severe valvular heart disease and outcomes in allogeneic stem cell transplantation","volume":"292","author":"Brusen","year":"2019","journal-title":"Int J Cardiol"},{"issue":"23","key":"10.1016\/j.bulcan.2022.03.014_bib0245","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","article-title":"Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bulcan.2022.03.014_bib0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11936-016-0447-9","article-title":"Cardiovascular complications of hematopoietic stem cell transplantation","volume":"18","author":"Blaes","year":"2016","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.bulcan.2022.03.014_bib0255","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/heartjnl-2021-319359","article-title":"The utility of strain imaging in the cardiac surveillance of bone marrow transplant patients [published online ahead of print, 2021 Jul 22]","volume":"108","author":"Deshmukh","year":"2022","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.bulcan.2022.03.014_bib0260","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/jcm8050690","article-title":"Pretransplant cardiac evaluation using novel technology","volume":"8","author":"Hemu","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.bulcan.2022.03.014_bib0265","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/ejhf.2017","article-title":"Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology","volume":"22","author":"Pudil","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.bulcan.2022.03.014_bib0270","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00277-012-1529-8","article-title":"not the prognostic all-rounder in elderly patients undergoing allogeneic stem cell transplantation","volume":"91","author":"Haas","year":"2012","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.bulcan.2022.03.014_bib0275","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2009.06.001","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction","volume":"15","author":"Qazilbash","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bulcan.2022.03.014_bib0280","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbmt.2014.10.011","article-title":"Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?","volume":"21","author":"Hurley","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bulcan.2022.03.014_bib0285","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","article-title":"Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor","volume":"68","author":"Goldberg","year":"1986","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bulcan.2022.03.014_bib0290","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.bmt.1704763","article-title":"Cardiac toxicity of high-dose chemotherapy","volume":"35","author":"Morandi","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.bulcan.2022.03.014_bib0295","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00277-016-2654-6","article-title":"The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT)","volume":"95","author":"Ishida","year":"2016","journal-title":"Ann Hematol"},{"issue":"12","key":"10.1016\/j.bulcan.2022.03.014_bib0300","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/sj.bmt.1705175","article-title":"Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation","volume":"36","author":"Kuittinen","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bulcan.2022.03.014_bib0305","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/bmt.2015.127","article-title":"Arrhythmias in the setting of hematopoietic cell transplants","volume":"50","author":"Tonorezos","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bulcan.2022.03.014_bib0310","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.3109\/10428194.2015.1122782","article-title":"Echocardiographic evaluation of the early cardiotoxic effect of hematopoietic stem cell transplantation in patients with hematologic malignancies","volume":"57","author":"Por\u0119ba","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"9","key":"10.1016\/j.bulcan.2022.03.014_bib0315","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"10.1016\/j.bulcan.2022.03.014_bib0320","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","article-title":"Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977\u20131997","volume":"28","author":"Murdych","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2022.03.014_bib0325","article-title":"Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management","volume":"1","author":"Dhesi","year":"2013","journal-title":"J Investigative Med High Impact Case Rep"},{"issue":"1","key":"10.1016\/j.bulcan.2022.03.014_bib0330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bmt.2009.97","article-title":"Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation","volume":"45","author":"Peres","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.bulcan.2022.03.014_bib0335","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/cncr.30534","article-title":"Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation","volume":"123","author":"Lin","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2022.03.014_bib0340","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","article-title":"Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation","volume":"3","author":"Dul\u00e9ry","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.bulcan.2022.03.014_bib0345","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1182\/bloodadvances.2021004846","article-title":"Cardiac toxicity after matched allogeneic hematopoietic cell transplantation in the post-transplant cyclophosphamide era","volume":"28","author":"Yeh","year":"2021","journal-title":"Blood Adv"},{"issue":"8","key":"10.1016\/j.bulcan.2022.03.014_bib0350","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/bmt.2017.62","article-title":"The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults","volume":"52","author":"Rotz","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"23","key":"10.1016\/j.bulcan.2022.03.014_bib0355","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bulcan.2022.03.014_bib0360","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/bmt.2015.64","article-title":"Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995\u00a0consecutive patients at a single center","volume":"50","author":"Miller","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2022.03.014_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.20042","article-title":"Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation","volume":"76","author":"Nakamae","year":"2004","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.bulcan.2022.03.014_bib0370","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.annonc.2019.10.023","article-title":"Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations","volume":"31","author":"Curigliano","year":"2020","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.bulcan.2022.03.014_bib0375","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2005-01-0035","article-title":"Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study","volume":"105","author":"Bhatia","year":"2005","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.bulcan.2022.03.014_bib0380","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bulcan.2022.03.014_bib0385","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2008.07165.x","article-title":"Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation","volume":"142","author":"Tichelli","year":"2008","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bulcan.2022.03.014_bib0390","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-155-1-201107050-00004","article-title":"Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation","volume":"155","author":"Chow","year":"2011","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.bulcan.2022.03.014_bib0395","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"14","key":"10.1016\/j.bulcan.2022.03.014_bib0400","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/bloodadvances.2018019117","article-title":"Prediction of cardiovascular disease among hematopoietic cell transplantation survivors","volume":"2","author":"Armenian","year":"2018","journal-title":"Blood Adv"},{"issue":"25","key":"10.1016\/j.bulcan.2022.03.014_bib0405","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/j.jacc.2019.10.038","article-title":"Cardiovascular events among adults treated with Chimeric Antigen Receptor T-Cells (CAR-T)","volume":"74","author":"Alvi","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.bulcan.2022.03.014_bib0410","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/pbc.20621","article-title":"Acute graft-versus-host disease of the heart","volume":"47","author":"Roberts","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2022.03.014_bib0415","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.bmt.1702744","article-title":"Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin","volume":"27","author":"Platzbecker","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.bulcan.2022.03.014_bib0420","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbmt.2005.07.002","article-title":"Cardiac manifestations of graft-versus-host disease","volume":"11","author":"Rackley","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.bulcan.2022.03.014_bib0425","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00277-012-1541-z","article-title":"Large pericardial effusion as a life-threatening complication after hematopoietic stem cell transplantation-association with chronic GVHD in late-onset adult patients","volume":"91","author":"Liu","year":"2012","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.bulcan.2022.03.014_bib0430","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/10428194.2014.926346","article-title":"Short-term cardiac toxicity of autologous hematopoietic stem cell transplant for multiple myeloma","volume":"56","author":"Gul","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.bulcan.2022.03.014_bib0435","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bmt.1703098","article-title":"Acute left ventricular failure following melphalan and fludarabine conditioning","volume":"28","author":"Ritchie","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2022.03.014_bib0440","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1703632","article-title":"Acute myocardial ischemia after high-dose therapy with BEAM regimen","volume":"30","author":"Genet","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2022.03.014_bib0445","first-page":"88","article-title":"Persistent heart failure following melphalan and\u00a0fludarabine\u00a0conditioning","volume":"20","author":"Newbery","year":"2019","journal-title":"J Cardiol Cases"},{"issue":"5","key":"10.1016\/j.bulcan.2022.03.014_bib0225","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.clml.2020.01.007","article-title":"Effect of the thiotepa dose in the tbf conditioning regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia in complete remission: a report from the EBMT Acute Leukemia Working Party","volume":"20","author":"El-Cheikh","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455122001540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455122001540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:37:14Z","timestamp":1757792234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455122001540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0007455122001540"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2022.03.014","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications cardiaques de la greffe de cellules souches h\u00e9matopo\u00ef\u00e9tiques\u00a0: recommandations de la SFGM-TC","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2022.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}